144 related articles for article (PubMed ID: 24687871)
21. Patient-Derived Gastric Carcinoma Xenograft Mouse Models Faithfully Represent Human Tumor Molecular Diversity.
Zhang T; Zhang L; Fan S; Zhang M; Fu H; Liu Y; Yin X; Chen H; Xie L; Zhang J; Gavine PR; Gu Y; Ni X; Su X
PLoS One; 2015; 10(7):e0134493. PubMed ID: 26217940
[TBL] [Abstract][Full Text] [Related]
22. Establishment, functional and genetic characterization of a colon derived large cell neuroendocrine carcinoma cell line.
Gock M; Mullins CS; Harnack C; Prall F; Ramer R; Göder A; Krämer OH; Klar E; Linnebacher M
World J Gastroenterol; 2018 Sep; 24(33):3749-3759. PubMed ID: 30197480
[TBL] [Abstract][Full Text] [Related]
23. A multicenter clinical study: personalized medication for advanced gastrointestinal carcinomas with the guidance of patient-derived tumor xenograft (PDTX).
Cheng Y; Qin SK; Li J; Dai GH; Shen BY; Ying JE; Ba Y; Liang H; Wang XB; Xu Y; Zhou L; Ding KF; Qin YR; Yang SJ; Guan WX; Zheng H; Wang Q; Song H; Zhu YP
J Cancer Res Clin Oncol; 2022 Mar; 148(3):673-684. PubMed ID: 33864522
[TBL] [Abstract][Full Text] [Related]
24. Application of Sequencing, Liquid Biopsies, and Patient-Derived Xenografts for Personalized Medicine in Melanoma.
Girotti MR; Gremel G; Lee R; Galvani E; Rothwell D; Viros A; Mandal AK; Lim KH; Saturno G; Furney SJ; Baenke F; Pedersen M; Rogan J; Swan J; Smith M; Fusi A; Oudit D; Dhomen N; Brady G; Lorigan P; Dive C; Marais R
Cancer Discov; 2016 Mar; 6(3):286-99. PubMed ID: 26715644
[TBL] [Abstract][Full Text] [Related]
25. A patient-derived orthotopic xenograft (PDOX) nude-mouse model precisely identifies effective and ineffective therapies for recurrent leiomyosarcoma.
Zhang Z; Hu K; Kiyuna T; Miyake K; Kawaguchi K; Igarashi K; Nelson SD; Li Y; Singh SR; Hoffman RM
Pharmacol Res; 2019 Apr; 142():169-175. PubMed ID: 30807865
[TBL] [Abstract][Full Text] [Related]
26. Fine-tuning patient-derived xenograft models for precision medicine approaches in leukemia.
Francis OL; Milford TA; Beldiman C; Payne KJ
J Investig Med; 2016 Mar; 64(3):740-4. PubMed ID: 26912005
[TBL] [Abstract][Full Text] [Related]
27. Trabectedin arrests a doxorubicin-resistant PDGFRA-activated liposarcoma patient-derived orthotopic xenograft (PDOX) nude mouse model.
Kiyuna T; Tome Y; Murakami T; Kawaguchi K; Igarashi K; Miyake K; Miyake M; Li Y; Nelson SD; Dry SM; Singh AS; Russell TA; Elliott I; Singh SR; Kanaya F; Eilber FC; Hoffman RM
BMC Cancer; 2018 Aug; 18(1):840. PubMed ID: 30126369
[TBL] [Abstract][Full Text] [Related]
28. Avatars Identify Genetic Sources of Drug Response.
Cancer Discov; 2016 Jan; 6(1):OF9. PubMed ID: 26573662
[TBL] [Abstract][Full Text] [Related]
29. Prioritizing therapeutic targets using patient-derived xenograft models.
Lodhia KA; Hadley AM; Haluska P; Scott CL
Biochim Biophys Acta; 2015 Apr; 1855(2):223-34. PubMed ID: 25783201
[TBL] [Abstract][Full Text] [Related]
30. Patient-derived xenografts: a valuable platform for clinical and preclinical research in pancreatic cancer.
Wang Y; Cui J; Wang L
Chin Clin Oncol; 2019 Apr; 8(2):17. PubMed ID: 30943729
[TBL] [Abstract][Full Text] [Related]
31. Establishment and characterization of cell lines from chromosomal instable colorectal cancer.
Maletzki C; Gock M; Randow M; Klar E; Huehns M; Prall F; Linnebacher M
World J Gastroenterol; 2015 Jan; 21(1):164-76. PubMed ID: 25574089
[TBL] [Abstract][Full Text] [Related]
32. Development of Personalized Therapeutic Strategies by Targeting Actionable Vulnerabilities in Metastatic and Chemotherapy-Resistant Breast Cancer PDXs.
Punzi S; Meliksetian M; Riva L; Marocchi F; Pruneri G; Criscitiello C; Orsi F; Spaggiari L; Casiraghi M; Della Vigna P; Luzi L; Curigliano G; Pelicci PG; Lanfrancone L
Cells; 2019 Jun; 8(6):. PubMed ID: 31216647
[TBL] [Abstract][Full Text] [Related]
33. Characterization of drug responses of mini patient-derived xenografts in mice for predicting cancer patient clinical therapeutic response.
Zhang F; Wang W; Long Y; Liu H; Cheng J; Guo L; Li R; Meng C; Yu S; Zhao Q; Lu S; Wang L; Wang H; Wen D
Cancer Commun (Lond); 2018 Sep; 38(1):60. PubMed ID: 30257718
[TBL] [Abstract][Full Text] [Related]
34. Thioredoxin Reductase Inhibitor Suppresses the Local Progression of Rhabdomyosarcoma With PDX Models.
Kinoshita H; Kinoshita S; Kamoda H; Hagiwara Y; Ohtori S; Yonemoto T
Cancer Genomics Proteomics; 2024; 21(2):178-185. PubMed ID: 38423598
[TBL] [Abstract][Full Text] [Related]
35. [Establishment of A Patient-derived Xenotransplantation Animal Model for Small Cell Lung Cancer and Drug Resistance Model].
Zhu Y; Huang W; Wu Y; Jia L; Li Y; Chen R; Guo L; Chen Q
Zhongguo Fei Ai Za Zhi; 2019 Jan; 22(1):6-14. PubMed ID: 30674387
[TBL] [Abstract][Full Text] [Related]
36. HER3 Targeting Sensitizes HNSCC to Cetuximab by Reducing HER3 Activity and HER2/HER3 Dimerization: Evidence from Cell Line and Patient-Derived Xenograft Models.
Wang D; Qian G; Zhang H; Magliocca KR; Nannapaneni S; Amin AR; Rossi M; Patel M; El-Deiry M; Wadsworth JT; Chen Z; Khuri FR; Shin DM; Saba NF; Chen ZG
Clin Cancer Res; 2017 Feb; 23(3):677-686. PubMed ID: 27358485
[TBL] [Abstract][Full Text] [Related]
37. Genomic signatures defining responsiveness to allopurinol and combination therapy for lung cancer identified by systems therapeutics analyses.
Tavassoly I; Hu Y; Zhao S; Mariottini C; Boran A; Chen Y; Li L; Tolentino RE; Jayaraman G; Goldfarb J; Gallo J; Iyengar R
Mol Oncol; 2019 Aug; 13(8):1725-1743. PubMed ID: 31116490
[TBL] [Abstract][Full Text] [Related]
38. Integrated Patient-Derived Models Delineate Individualized Therapeutic Vulnerabilities of Pancreatic Cancer.
Witkiewicz AK; Balaji U; Eslinger C; McMillan E; Conway W; Posner B; Mills GB; O'Reilly EM; Knudsen ES
Cell Rep; 2016 Aug; 16(7):2017-31. PubMed ID: 27498862
[TBL] [Abstract][Full Text] [Related]
39. Drug resistance profiling of a new triple negative breast cancer patient-derived xenograft model.
Matossian MD; Burks HE; Elliott S; Hoang VT; Bowles AC; Sabol RA; Wahba B; Anbalagan M; Rowan B; Abazeed ME; Bunnell BA; Moroz K; Miele L; Rhodes LV; Jones SD; Martin EC; Collins-Burow BM; Burow ME
BMC Cancer; 2019 Mar; 19(1):205. PubMed ID: 30845999
[TBL] [Abstract][Full Text] [Related]
40. Integrated analysis of transcriptome in cancer patient-derived xenografts.
Li H; Zhu Y; Tang X; Li J; Li Y; Zhong Z; Ding G; Li Y
PLoS One; 2015; 10(5):e0124780. PubMed ID: 25951608
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
